financetom
Business
financetom
/
Business
/
Hong Kong's CKI emerges as leading contender for Thames Water, The Times reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hong Kong's CKI emerges as leading contender for Thames Water, The Times reports
Aug 12, 2025 3:34 PM

Aug 12 (Reuters) -

Hong Kong's CK Infrastructure Holdings ( CKISF ) has

emerged as a leading contender to take over Thames Water and

could assume control within weeks if Britain's largest water

utility is placed into special ­administration, The Times

reported on Tuesday.

Reuters could not immediately confirm the report.

CKI has indicated it would be prepared to operate under

tougher penalties for environmental breaches, a regime that

Thames Water's creditors say is financially unviable, the report

said.

Thames Water did not respond immediately to a Reuters

request for comment outside regular business hours, while CKI

could not be immediately reached for comment.

Earlier on Tuesday, Reuters reported that Britain had

appointed FTI Consulting ( FCN ) to advise on contingency plans

for heavily indebted and loss-making Thames Water to be

placed into a special administration regime.

Thames Water is seeking to

avoid nationalisation

by securing 5 billion pounds ($6.75 billion) of financing

from senior bondholders. In July, the company said it had enough

cash to operate for 12 months but needs a reset of regulations

for any deal to proceed.

($1 = 0.7409 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck second quarter tops Street view on strong Keytruda sales
Merck second quarter tops Street view on strong Keytruda sales
Jul 30, 2024
July 30 (Reuters) - Merck & Co ( MRK ) posted higher-than-expected second-quarter results on Tuesday on strong growth of its blockbuster cancer immunotherapy Keytruda, the world's best-selling prescription medicine. New Jersey-based Merck ( MRK ) slightly raised its full-year sales projections, following other big pharmaceutical companies like Roche, Johnson & Johnson and Bristol Myers Squibb, which lifted their forecasts...
Procter & Gamble misses sales expectations on slowing demand
Procter & Gamble misses sales expectations on slowing demand
Jul 30, 2024
(Reuters) -Procter & Gamble missed Wall Street expectations for fourth-quarter sales on Tuesday, on weak demand for its skincare products in major market China and waning price benefitsin the U.S. and Europe for its home care products. Shares of the Tide detergent maker fell 2.3% in premarket trading. P&G has scaled back on further price hikes and instead have been...
Alaska Airlines, Hawaiian Airlines extend review period of deal amid antitrust scrutiny
Alaska Airlines, Hawaiian Airlines extend review period of deal amid antitrust scrutiny
Jul 30, 2024
July 30 (Reuters) - Alaska Air Group ( ALK ) has agreed to extend the review period for the proposed $1.9 billion acquisition of rival Hawaiian Airlines amid antitrust scrutiny from the U.S. Department of Justice, the carrier said in a filing on Tuesday. Our airlines have mutually agreed with the DOJ on a brief extension of the formal review...
Pfizer raises annual profit forecast after better-than-expected COVID sales
Pfizer raises annual profit forecast after better-than-expected COVID sales
Jul 30, 2024
July 30 (Reuters) - U.S. drugmaker Pfizer ( PFE ) on Tuesday raised its annual profit forecast after reporting better-than-expected sales of its COVID vaccine and antiviral treatment. New Jersey-based Pfizer ( PFE ) now expects annual profit to be in the range of $2.45 to $2.65 per share, compared with its prior profit forecast of $2.15 to $2.35 per...
Copyright 2023-2026 - www.financetom.com All Rights Reserved